GSK/Par Paxil Generic Deal Upheld In Court; FTC Closes Patent Investigation

GlaxoSmithKline's "authorized" generic Paxil agreement with Par does not raise any antitrust concerns, Chicago federal court Judge Richard Posner ruled Oct. 29

More from Archive

More from Pink Sheet